New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AbbVie Inc.

ABBV

Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue
+10.3%
EPS
+2,270.0%
Free cash flow
+9.97%
Total debt
+17.7%

Quarter to September 2026, against a year earlier

288.73 5.22 +1.84%
Market cap
$501.2B
P/E
48.8×
Fwd P/E FY26e
37.6×
Dividend yield
2.44%
F-score
8/9
ROIC
20.2%
Net debt / EBITDA
2.6×
Payout ratio
1.2×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $62.2B more in debt than it holds in cash and short-term investments. Debt has risen from $36.8B to $67.5B since FY16. Liabilities are $3.2B more than assets: shareholders’ equity is negative. What is a balance sheet?

Dec 31, 2025 · total $134.0B

Owns

$104.9BLong-term assets
$23.8BOther short-term assets
$5.3BCash & short-term investments

Funded by

$69.7BOther liabilities
$67.5BDebt

Debt is 50.4% of the total; liabilities are $3.2B more than assets.

Net debt has held near 46% of assets since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$66.1B$70.8B$59.4B$89.1B$150.6B$146.5B$138.8B$134.7B$135.2B$134.0B
Net debt (debt less cash)$30.4B$27.6B$32.2B$26.8B$77.6B$66.9B$54.0B$46.6B$61.6B$62.2B
Net debt ÷ assets (right axis)46.0%39.0%54.3%30.1%51.5%45.6%38.9%34.6%45.6%46.5%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
16,187.00 21,223.00 16,945.00 49,519.00 24,173.00 27,928.00 28,463.00 33,002.00 25,582.00 29,062.00
Total non-current assets
49,912.00 49,563.00 42,407.00 39,596.00 126,392.00 118,601.00 110,342.00 101,709.00 109,579.00 104,898.00
Total Assets
66,099.00 70,786.00 59,352.00 89,115.00 150,565.00 146,529.00 138,805.00 134,711.00 135,161.00 133,960.00
Total current liabilities
9,781.00 16,641.00 17,239.00 15,585.00 28,661.00 35,194.00 29,538.00 37,841.00 38,749.00 43,289.00
Total non-current liabilities
51,682.00 49,048.00 50,559.00 81,702.00 108,807.00 95,899.00 91,980.00 86,473.00 93,048.00 93,899.00
Total liabilities
61,463.00 65,689.00 67,798.00 97,287.00 137,468.00 131,093.00 121,518.00 124,314.00 131,797.00 137,188.00
Common Equity (Total)
4,636.00 5,097.00 (8,446.00) (8,172.00) 13,097.00 15,436.00 17,287.00 10,397.00 3,364.00 (3,228.00)
Shareholders Equity (Total)
4,636.00 5,097.00 (8,446.00) (8,172.00) 13,097.00 15,436.00 17,287.00 10,397.00 3,364.00 (3,228.00)
Total Debt
36,842.00 37,368.00 40,310.00 66,728.00 86,056.00 76,684.00 63,271.00 59,385.00 67,144.00 67,496.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026